指南与共识腹部US

马来西亚肝细胞癌预防与早期检测共识声明

The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia.
指南 / 共识 · J Gastroenterol Hepatol · 2026-08-14

共识推荐高危人群每6个月联合超声与血清AFP监测,并强调新型生物标志物、影像辅助及基层早期识别的重要性。

要点

  • 高危人群应每6个月行超声联合血清AFP监测
  • 重视非侵入性纤维化评估在高危人群早期识别中的作用
  • 强调从基层到专科的明确转诊路径和多学科协作

核心结论

  • 对高危人群实施主动监测对改善肝细胞癌早期发现和生存至关重要。
  • 提高意识、优化高危人群识别及清晰转诊路径可提升监测效能。

研究设计与样本

  • 制定机构为马来西亚胃肠病与肝病学会,采用改良德尔菲法形成专家共识。

诊断标准与关键数值

  • 现阶段监测标准为每6个月超声联合血清甲胎蛋白(AFP)检查。
  • 新型生物标志物与影像可作为辅助手段提高肝细胞癌早期检出率。

临床应用与阅片要点

  • 对乙肝、丙肝患者及肝硬化等高危人群执行规范的6个月超声+AFP监测可提高早期发现率。
  • 在基层医疗和内分泌环境中采用非侵入性纤维化评估有助于早期识别高危患者。
  • 建立清晰的基层到肝病专科转诊路径,并推动多学科协作可改善监测的连续性和疗效。

局限性

  • 共识主要基于专家意见,部分推荐可能缺乏高水平证据支持。
  • 未报告共识达成的具体投票结果及证据分级细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence-based, locally relevant recommendations for the prevention and early detection of HCC.

METHODS: Nineteen experts from gastroenterology and hepatology, radiology, endocrinology, and family medicine were convened by the Malaysian Society of Gastroenterology and Hepatology. A modified Delphi method was used to prepare the consensus statements.

RESULTS: Twenty-two out of 26 statements achieved consensus and are included in this document. These statements addressed HCC prevention, risk stratification, surveillance strategies, barriers to effective surveillance, and recommendations on linkage to specialized hepatology care. Preventive measures include universal Hepatitis B vaccination for newborns, treatment of Hepatitis B and C, and lifestyle modification. Six-monthly surveillance with ultrasound and serum alpha-fetoprotein (AFP) is the current standard of care; however, adjunctive novel biomarkers and imaging can improve early HCC detection. Early identification of at-risk patients using noninvasive fibrosis assessment in the primary healthcare and endocrinology setting are equally important.

CONCLUSION: Active surveillance of at-risk patients is crucial in improving early HCC detection and patient survival. The efficacy of HCC surveillance requires greater awareness, better identification of at-risk patients and clear referral pathways, supported by multidisciplinary collaboration. This consensus document provides a practical, evidence-based approach to optimizing HCC prevention and early detection, with the goal of improving patient outcomes.

来源:J Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lau, Kok, Tan, et al. The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia. J Gastroenterol Hepatol. 2026. PMID: 42601228. doi:10.1111/jgh.70643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。